Atripla

Express Scripts to Drop Big Sellers From AbbVie, Gilead in 2019
Bloomberg
Tue, 08/7/18 - 11:24 am
Express Scripts
PBMs
Gilead Sciences
HIV
Atripla
AbbVie
Mavyret
hepatitis C
Can Gilead Dominate The HIV Drug Market Again in 2014?
Motley Fool
Wed, 03/12/14 - 06:58 pm
HIV
Gilead Sciences
Stribild
Truvada
Atripla
Innovations In HIV: Johnson & Johnson, Glaxo Vs. Gilead
Seeking Alpha
Mon, 07/22/13 - 10:26 am
HIV
Atripla
JNJ
Pfizer
GSK
Gilead
Dolutegravir
Edurant
China
TMC310911
Consider Biotech Gilead Sciences Because Of Atripla, Sofosbuvir And Great R&D
Seeking Alpha
Fri, 06/14/13 - 08:27 am
sofosbuvir
Atripla
Gilead
HIV
R&D
hepatitis C
Glaxo, Shionogi Say HIV Drug Beats Gilead Atripla In Test
Bloomberg
Wed, 07/11/12 - 10:19 am
GSK
HIV
AIDS
Shionogi
Gilead
Atripla
Dolutegravir
Gilead’s Experimental 4-in-1 AIDS Pill Effective as Current Drug in Study
Bloomberg
Wed, 03/7/12 - 03:36 pm
AIDS
HIV
Gilead
Atripla
Quad
Lofty hopes confront Gilead's 4-drug HIV pill
Reuters
Mon, 09/12/11 - 10:10 am
Gilead
HIV
Quad
Atripla
Analyst sees low physician expectations for new Gilead HIV treatment Complera
Yahoo/AP
Thu, 08/11/11 - 11:10 am
Gilead
HIV
Complera
JNJ
Atripla
Bristol-Myers Squibb
Gilead gets subpoena from Justice Department
MarketWatch
Sat, 06/11/11 - 10:23 am
Gilead Sciences
Atripla
Emtriva
Hepsera
Letairis
Truvada
Viread
Gilead's Quad HIV Pill Better Than Best-Selling Atripla in 48-Week Study
Bloomberg
Mon, 09/13/10 - 12:48 pm
Gilead Sciences
Quad
HIV
Atripla
Merck
GSK
Gilead CEO Sees Sales Gains on Earlier AIDS Treatment
Bloomberg
Fri, 05/29/09 - 03:43 am
Gilead Sciences
AIDS
Atripla
Truvada
Viread
Gilead Sciences sues Teva over generic AIDS drug
Globes, Israel
Sun, 05/17/09 - 01:40 pm
Gilead Sciences
Teva Pharmaceuticals
Atripla
Truvada